Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
83.98
USD
|
+0.97%
|
|
-0.23%
|
-11.18%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,305
|
2,680
|
2,786
|
2,366
|
2,115
|
1,880
|
-
|
-
|
Enterprise Value (EV)
1 |
2,305
|
2,680
|
2,990
|
2,366
|
2,115
|
1,880
|
1,880
|
1,880
|
P/E ratio
|
-
|
-
|
21
x
|
16.7
x
|
54
x
|
32.2
x
|
17.6
x
|
-
|
Yield
|
1.01%
|
0.95%
|
1.01%
|
1.29%
|
1.55%
|
1.82%
|
1.92%
|
-
|
Capitalization / Revenue
|
1.24
x
|
1.43
x
|
1.19
x
|
0.85
x
|
0.91
x
|
0.79
x
|
0.73
x
|
0.7
x
|
EV / Revenue
|
1.24
x
|
1.43
x
|
1.19
x
|
0.85
x
|
0.91
x
|
0.79
x
|
0.73
x
|
0.7
x
|
EV / EBITDA
|
10.1
x
|
10.4
x
|
10.4
x
|
7.84
x
|
11.7
x
|
7.77
x
|
6.27
x
|
-
|
EV / FCF
|
-
|
-
|
-25.6
x
|
-21.5
x
|
-24.7
x
|
12.7
x
|
9.82
x
|
10.1
x
|
FCF Yield
|
-
|
-
|
-3.91%
|
-4.65%
|
-4.04%
|
7.87%
|
10.2%
|
9.9%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
22,505
|
22,461
|
22,416
|
22,228
|
22,367
|
22,381
|
-
|
-
|
Reference price
2 |
102.4
|
119.3
|
124.3
|
106.5
|
94.55
|
83.98
|
83.98
|
83.98
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,859
|
1,870
|
2,346
|
2,773
|
2,326
|
2,373
|
2,584
|
2,684
|
EBITDA
1 |
227.5
|
258.3
|
269.2
|
302
|
180
|
242
|
299.6
|
-
|
EBIT
1 |
148.8
|
178.4
|
178.3
|
207.3
|
58.61
|
112.1
|
165.8
|
187.9
|
Operating Margin
|
8%
|
9.54%
|
7.6%
|
7.48%
|
2.52%
|
4.72%
|
6.41%
|
7%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
172.5
|
188.7
|
48.39
|
93.6
|
146.8
|
-
|
Net income
1 |
-
|
-
|
137.8
|
147.2
|
40.2
|
59.45
|
102.8
|
-
|
Net margin
|
-
|
-
|
5.87%
|
5.31%
|
1.73%
|
2.51%
|
3.98%
|
-
|
EPS
2 |
-
|
-
|
5.920
|
6.380
|
1.750
|
2.610
|
4.780
|
-
|
Free Cash Flow
1 |
-
|
-
|
-109
|
-110.1
|
-85.46
|
148
|
191.4
|
186
|
FCF margin
|
-
|
-
|
-4.65%
|
-3.97%
|
-3.67%
|
6.24%
|
7.41%
|
6.93%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
61.15%
|
63.9%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
248.95%
|
186.1%
|
-
|
Dividend per Share
2 |
1.030
|
1.130
|
1.250
|
1.370
|
1.470
|
1.525
|
1.610
|
-
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
602.7
|
610
|
675.3
|
751.6
|
719.2
|
627.2
|
651.4
|
580
|
562.2
|
532.1
|
575.8
|
586.7
|
615
|
595.4
|
635.9
|
EBITDA
1 |
62.19
|
46.22
|
86.26
|
101
|
78.36
|
36.38
|
48.7
|
45.8
|
45.82
|
37.5
|
46.75
|
59.15
|
72.88
|
65.22
|
70.3
|
EBIT
1 |
39.55
|
27.23
|
63.35
|
77.64
|
54.66
|
11.69
|
21.06
|
17.81
|
19.52
|
0.23
|
17
|
29.4
|
39.27
|
26.4
|
35.2
|
Operating Margin
|
6.56%
|
4.46%
|
9.38%
|
10.33%
|
7.6%
|
1.86%
|
3.23%
|
3.07%
|
3.47%
|
0.04%
|
2.95%
|
5.01%
|
6.39%
|
4.43%
|
5.54%
|
Earnings before Tax (EBT)
1 |
39.32
|
22.24
|
59.39
|
69.54
|
50.46
|
9.311
|
19.9
|
16.31
|
15.84
|
-3.666
|
11.95
|
23.2
|
36.3
|
22.2
|
31.05
|
Net income
1 |
36.92
|
17
|
44.81
|
52.13
|
39.38
|
10.83
|
16.14
|
12.68
|
12.57
|
-1.193
|
7.55
|
14.7
|
23.05
|
14.1
|
21.6
|
Net margin
|
6.13%
|
2.79%
|
6.64%
|
6.94%
|
5.48%
|
1.73%
|
2.48%
|
2.19%
|
2.24%
|
-0.22%
|
1.31%
|
2.51%
|
3.75%
|
2.37%
|
3.4%
|
EPS
2 |
1.590
|
0.7300
|
1.930
|
2.260
|
1.710
|
0.4700
|
0.7000
|
0.5500
|
0.5500
|
-0.0500
|
0.2900
|
0.7800
|
1.020
|
0.5200
|
0.9000
|
Dividend per Share
2 |
0.3050
|
0.3350
|
0.3350
|
0.3350
|
0.3350
|
0.3650
|
0.3650
|
0.3650
|
-
|
0.3750
|
0.3775
|
0.3775
|
0.3775
|
0.3975
|
0.4050
|
Announcement Date
|
10/20/21
|
2/17/22
|
4/26/22
|
7/27/22
|
10/19/22
|
2/16/23
|
4/25/23
|
7/26/23
|
10/18/23
|
2/20/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
204
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.7594
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-109
|
-110
|
-85.5
|
148
|
191
|
186
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
106
|
126
|
194
|
302
|
260
|
130
|
121
|
120
|
Capex / Sales
|
5.68%
|
6.73%
|
8.29%
|
10.87%
|
11.19%
|
5.48%
|
4.7%
|
4.47%
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
83.98
USD Average target price
100.5
USD Spread / Average Target +19.67% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.18% | 1.88B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|